Work

“Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication

Year: 2020

Type: article

Source: AIDS and Behavior

DOI: 10.1007/s10461-019-02769-1

Authors: Ilona Fridman, Peter A. Ubel, Jennifer Blumenthal-Barby, Cameron V. England, Judith S. Currier, Nir Eyal, Kenneth A. Freedberg, Scott D. Halpern, Colleen F. Kelley, Daniel R. Kuritzkes, Catherine N. Le, Jeffrey L. Lennox, Kathryn I. Pollak, Brian J. Zikmund-Fisher, Karen A. Scherr

Institutions: Duke University, Baylor College of Medicine, Grady Memorial Hospital, Emory University, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Leonard Davis Institute of Health Economics, University of Pennsylvania, HOPE Clinic, Duke Cancer Institute, University of Michigan

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: Cost-Effectiveness of Preventing HIV Complications, HIV cure studies: risk, risk perception, and ethics, HIV cure studies: risk, risk perception, and ethics, Center for AIDS Research at Emory University

OpenAlex ID: W2997931376

FWCI: 0.22

Cites: 28

Cited by: 10

Related to: 10